Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Amplification strategies in MR imaging: activation and accumulation of sensing contrast agents (SCAs).

Querol M, Bogdanov A Jr.

J Magn Reson Imaging. 2006 Nov;24(5):971-82. Review.

PMID:
17024658
2.

[Visualization of the enzymatic activity in living systems using activated NMR contrast agents].

Bogdanov AA, Querol M, Chen JW.

Biofizika. 2007 May-Jun;52(3):389-400. Review. Russian.

PMID:
17633527
3.

Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.

Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E.

Acc Chem Res. 2009 Jul 21;42(7):822-31. doi: 10.1021/ar800192p. Review.

PMID:
19534516
4.

Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.

Pérez-Mayoral E, Negri V, Soler-Padrós J, Cerdán S, Ballesteros P.

Eur J Radiol. 2008 Sep;67(3):453-8. doi: 10.1016/j.ejrad.2008.02.048. Epub 2008 May 1. Review.

PMID:
18455343
5.

Improved detection of gadolinium enhancement using magnetization transfer imaging.

Elster AD, Mathews VP, King JC, Hamilton CA.

Neuroimaging Clin N Am. 1994 Feb;4(1):185-92. Review.

PMID:
8130949
6.

Contrast agents: magnetic resonance.

Burtea C, Laurent S, Vander Elst L, Muller RN.

Handb Exp Pharmacol. 2008;(185 Pt 1):135-65. doi: 10.1007/978-3-540-72718-7_7. Review.

PMID:
18626802
7.

Effects of contrast dose, delayed imaging, and magnetization transfer saturation on gadolinium-enhanced MR imaging of brain lesions.

Mathews VP, Caldemeyer KS, Ulmer JL, Nguyen H, Yuh WT.

J Magn Reson Imaging. 1997 Jan-Feb;7(1):14-22. Review.

PMID:
9039589
8.

Molecular imaging with targeted contrast agents.

Makowski MR, Wiethoff AJ, Jansen CH, Botnar RM.

Top Magn Reson Imaging. 2009 Aug;20(4):247-59. doi: 10.1097/RMR.0b013e3181ea28b1. Review.

PMID:
20805735
9.

Basic principles of magnetic resonance contrast agents.

Kirsch JE.

Top Magn Reson Imaging. 1991 Mar;3(2):1-18. Review.

PMID:
2025431
10.

CEST and PARACEST MR contrast agents.

Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE.

Acta Radiol. 2010 Oct;51(8):910-23. doi: 10.3109/02841851.2010.502126. Review.

PMID:
20828299
12.

Environment-sensitive and enzyme-sensitive MR contrast agents.

Querol M, Bogdanov A Jr.

Handb Exp Pharmacol. 2008;(185 Pt 2):37-57. doi: 10.1007/978-3-540-77496-9_3. Review.

PMID:
18626598
13.

MR techniques for in vivo molecular and cellular imaging.

Delikatny EJ, Poptani H.

Radiol Clin North Am. 2005 Jan;43(1):205-20. Review.

PMID:
15693657
14.

Tissue-specific MR contrast agents.

Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H.

Eur J Radiol. 2003 Apr;46(1):33-44. Review.

PMID:
12648800
15.

Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside.

Croisille P, Revel D, Saeed M.

Eur Radiol. 2006 Sep;16(9):1951-63. Epub 2006 Apr 22. Review.

PMID:
16633792
16.

Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology.

Winter PM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Jul-Aug;4(4):389-98. doi: 10.1002/wnan.1167. Epub 2012 Mar 15. Review.

PMID:
22422650
17.

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.

Caravan P.

Chem Soc Rev. 2006 Jun;35(6):512-23. Epub 2006 May 3. Review.

PMID:
16729145
18.

Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.

Cheng W, Ping Y, Zhang Y, Chuang KH, Liu Y.

J Healthc Eng. 2013;4(1):23-45. doi: 10.1260/2040-2295.4.1.23. Review.

19.

Dendrimer-based nanosized MRI contrast agents.

Kobayashi H, Brechbiel MW.

Curr Pharm Biotechnol. 2004 Dec;5(6):539-49. Review.

PMID:
15579043
20.

Introduction to the gadolinium class.

Brasch RC.

J Comput Assist Tomogr. 1993;17 Suppl 1:S14-8. Review.

PMID:
8486826

Supplemental Content

Support Center